Using bisulfite treatment to maintain a marker for methylated cytosine residues, 50% of HCC patients from China have been observed exhibiting GSTP1 promoter hypermethylation on ctDNA extracted from serum. Here, GSTP1 is linked to hepatocellular carcinoma.